AN ACT to amend Tennessee Code Annotated, Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.
Impact
Should SB1765 pass, it would impact Tennessee's regulatory framework for prescription drug procurement, potentially leading to significant cost savings for the state through lower drug prices sourced from Canada. This initiative could benefit state healthcare programs, including TennCare, ultimately impacting the affordability of prescription drugs for residents. However, the bill places considerable expectations on the departments to produce comprehensive reports and proposals for implementation following federal approval.
Summary
Senate Bill 1765 aims to amend several sections of the Tennessee Code Annotated concerning prescription drugs by allowing the state to explore the importation of safe and effective prescription medications from Canada. The bill mandates that by January 1, 2025, the departments of finance and health collaborate to request federal approval for this importation. The request must demonstrate compliance with federal safety standards and include an analysis of potential cost savings for the state, addressing regulatory compliance for suppliers from Canada.
Sentiment
The sentiment surrounding SB1765 appears to be generally supportive, particularly among those advocating for healthcare affordability and access. Proponents highlight the potential for significant savings and improved access to medications for all residents. However, there are concerns regarding the safety and efficacy of imported drugs, as well as the ability of state agencies to efficiently manage this program should it be implemented.
Contention
Notable points of contention include discussions about the safety and regulatory compliance of imported drugs. Critics may question whether the benefits of potential cost savings outweigh the risks associated with sourcing medications from foreign suppliers. Additionally, issues surrounding federal regulations and their impact on the effectiveness of the bill could be raised, particularly regarding how well the state can meet compliance requirements for drug importation.
Crossfiled
AN ACT to amend Tennessee Code Annotated, Title 8; Title 33; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to prescription drugs.
AN ACT to amend Tennessee Code Annotated, Title 4; Title 33; Title 49; Title 53; Title 55; Title 56; Title 63; Title 68 and Title 71, relative to healthcare professions.